Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
13541
-
13542
-
13543
-
13544
-
13545
-
13546
-
13547
-
13548
HS induces a rapid degeneration of the nuclei of the MB neurons in the absence of dPGAM5.
Published 2012“…<p>The number of cell bodies of the KCs decreases in HS-treated <i>PGAM5<sup>1</sup></i> flies. …”
-
13549
-
13550
Altered ERK 1/2 and Smad 1/5/8 phosphorylation observed in primary rat hippocampal cells upon iAβ expression.
Published 2018“…<b>(B)</b> Plot of relative densitometry analysis of phospho-ERK 1/2 with data corresponding to biological replicates shown as mean ± SE (n = 3). Statistically significant (p < 0.05) decrease in phospho-ERK 1/2 observed in iAβ transduced cells restored upon pre-treatment with PLX4032. …”
-
13551
-
13552
Deletion of <i>Ulk1</i> inhibits neointima formation by enhancing KAT2A/GCN5-mediated acetylation of TUBA/α-tubulin <i>in vivo</i>
Published 2021“…Mechanistically, <i>Ulk1</i> deletion inhibited autophagic degradation of histone acetyltransferase protein KAT2A/GCN5 (K[lysine] acetyltransferase 2A), resulting in accumulation of KAT2A that directly acetylated TUBA/α-tubulin and subsequently increased protein levels of acetylated TUBA. …”
-
13553
-
13554
-
13555
-
13556
Identification of NFYB-dependent E2F1 target genes.
Published 2015“…Real-time PCR validation of target gene expression decrease for SIVA1 (D), SFRP1 (E), FOLH1 (F), and PRKCZ (G) following NFYB knockdown. …”
-
13557
-
13558
-
13559
S1 File -
Published 2024“…</p><p>Results</p><p>Among the 1015 surveyed individuals, the geometric mean concentration (GMC) of Anti-PT-IgG was 10.52 (95% CI: 9.96–11.11) IU/mL, with a recent infection rate of 1.58%, a serum positivity rate of 11.43%, and a proportion with <5IU/mL of 40.49%. …”
-
13560